Motif Bio looks to possible Nasdaq listing
8 June 2015: Motiv Bio CEO tells IG that while AIM, the alternative investment market, is better understanding value in biotech stocks, a Nasdaq listing is an option for the company. This, Mr Lumsdan says, should help boost the company’s valuation. Related Posts:Technical analysis on Nasdaq for November 7th, 2023. November 7, 2023 Red line- […]